Elagolix Sódico
1-[2-fluoro-6- ((trifluorometil) bencil]-5-yodo-6-metilpirimidina-2,4 ((1H,3H) -diona (1150560-54-5)
1-[2-fluoro-6-(trifluoromethyl)benzyl]-5-iodo-6-methylpyrimidine-2,4(1H,3H)-dione is an intermediate of Elagolix Sodium. Product Name: 1-[2-fluoro-6-(trifluoromethyl)benzyl]-5-iodo-6-methylpyrimidine-2,4(1H,3H)-dione CAS No.: 1150560-54-5 Assay: 98% End Use: Elagolix Sodium Molecular Formula: C13H9F4IN2O2 Molecular Weight: 428.12 Shelf Life: 2 Years Package: 25kg/drum
5-bromo-1-(2-fluoro-6-trifluorometil-bencil)-6-metil-1H-pirimidina-2,4-diona (830346-48-0)
5-Bromo-1-(2-fluoro-6-trifluoromethyl-benzyl)-6-methyl-1H-pyrimidine-2,4-dione is an intermediate of Elagolix Sodium. Product Name: 5-Bromo-1-(2-fluoro-6-trifluoromethyl-benzyl)-6-methyl-1H-pyrimidine-2,4-dione CAS No.: 830346-48-0 Assay: 98% End Use: Elagolix Sodium Molecular Formula: C13H9F4BrN2O2 Molecular Weight: 381.12 Shelf Life: 2 Years Package: 25kg/drum
Las sustancias enumeradas en el anexo I del Reglamento (CE) n.o 1907/2006 deben incluirse en el anexo II del Reglamento (CE) n.o 1907/2006 del Parlamento Europeo y del Consejo.
5-(2-Fluoro-3-methoxyphenyl)-1-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-6-methyl-2,4(1H,3H)-pyrimidinedione is an intermediate of Elagolix Sodium. Product Name: 5-(2-Fluoro-3-methoxyphenyl)-1-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-6-methyl-2,4(1H,3H)-pyrimidin CAS No.: 1150560-59-0 Assay: 98% End Use: Elagolix Sodium Molecular Formula: C20H15F5N2O3 Molecular Weight: 426.34 Shelf Life: 2 Years Package: 25kg/drum
Ácido bencénico acético, 4-fluoro-alfa- ((1-metiletil) -, (.alfa.S) - (830346-47-9)
Benzeneacetic acid, 4-fluoro-.alpha.-(1-methylethyl)-, (.alpha.S)- is a key intermediate of Elagolix Sodium. Product Name: Benzeneacetic acid, 4-fluoro-.alpha.-(1-methylethyl)-, (.alpha.S)- CAS No.: 830346-47-9 Assay: 98% End Use: Elagolix Sodium Molecular Formula: C13H10F4N2O2 Molecular Weight: 302.22 Shelf Life: 2 Years Package: 25kg/drum
Elágolix de sodio (832720-36-2)
Elagolix sodium (ABT-620) is a small molecule, orally active gonadotropin-releasing hormone (GnRH) receptor antagonist. It has the ability to suppress estradiol (E2) concentrations in a dose-dependent manner. Elagolix is the first orally available GnRH antagonist, and as such may provide patients with relief from the painful symptoms of endometriosis while offering advantages over currently available injectable peptide-based treatments. The estimated patient population is
Ácido 2-fluoro-3-metoxifenilborónico (352303-67-4)
2-fluoro-3-methoxyphenylboronic acid is an intermediate of Elagolix Sodium. Product Name: 2-fluoro-3-methoxyphenylboronic acid CAS No.: 352303-67-4 Assay: 98% End Use: Elagolix Sodium Molecular Formula: C7H8BFO3 Molecular Weight: 169.95 Shelf Life: 2 Years Package: 25kg/drum